Published in Cornea on October 01, 2009
Corneal neovascularization: an anti-VEGF therapy review. Surv Ophthalmol (2012) 1.21
Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin). Ocul Surf (2012) 1.08
Ocular delivery of macromolecules. J Control Release (2014) 0.91
Neovascularization of coronary tunica intima (DIT) is the cause of coronary atherosclerosis. Lipoproteins invade coronary intima via neovascularization from adventitial vasa vasorum, but not from the arterial lumen: a hypothesis. Theor Biol Med Model (2012) 0.86
Emerging techniques to treat corneal neovascularisation. Eye (Lond) (2011) 0.82
Corneal endothelial safety following subconjunctival and intrastromal injection of bevacizumab for corneal neovascularization. Int Ophthalmol (2013) 0.77
Intrastromal delivery of bevacizumab using microneedles to treat corneal neovascularization. Invest Ophthalmol Vis Sci (2014) 0.77
Prophylactic effect of topical silica nanoparticles as a novel antineovascularization agent for inhibiting corneal neovascularization following chemical burn. Adv Biomed Res (2015) 0.76
Safety of bevacizumab on extraocular muscle in a rabbit model. Korean J Ophthalmol (2012) 0.75
Curcumin, A Potential Therapeutic Candidate for Anterior Segment Eye Diseases: A Review. Front Pharmacol (2017) 0.75
The anti-inflammatory and anti-angiogenic role of mesenchymal stem cells in corneal wound healing following chemical injury. Stem Cells (2008) 1.77
Implementation of Consolidated HIS: Improving Quality and Efficiency of Healthcare. Healthc Inform Res (2010) 1.54
Eyelid Tattooing Induces Meibomian Gland Loss and Tear Film Instability. Cornea (2015) 1.40
Seoul National University Bundang Hospital's Electronic System for Total Care. Healthc Inform Res (2012) 1.10
Transscleral fixation of a foldable intraocular lens in aphakic vitrectomized eyes. J Cataract Refract Surg (2003) 1.09
A case of retained graphite anterior chamber foreign body masquerading as stromal keratitis. Korean J Ophthalmol (2011) 1.00
Clinical features, predisposing factors, and treatment outcomes of scleritis in the Korean population. Korean J Ophthalmol (2010) 1.00
Interleukin-17 in various ocular surface inflammatory diseases. J Korean Med Sci (2011) 1.00
Experience of Comamonas acidovorans keratitis with delayed onset and treatment response in immunocompromised cornea. Korean J Ophthalmol (2008) 0.98
Clinical and pathological characteristics of ocular surface squamous neoplasia in an Asian population. Graefes Arch Clin Exp Ophthalmol (2013) 0.98
Intraocular lens power calculation using IOLMaster and various formulas in short eyes. Korean J Ophthalmol (2011) 0.97
Corneoscleral cyst treated with distilled water injection. Korean J Ophthalmol (2002) 0.95
A case of cataract surgery without pupillary device in the eye with iridoschisis. Korean J Ophthalmol (2008) 0.95
One-year outcome of argon laser photocoagulation of pinguecula. Cornea (2013) 0.95
Efficacy of pig-to-rhesus lamellar corneal xenotransplantation. Invest Ophthalmol Vis Sci (2011) 0.94
Corneal endothelial dysfunction associated with amantadine toxicity. Cornea (2008) 0.94
Processing porcine cornea for biomedical applications. Tissue Eng Part C Methods (2009) 0.94
Protective effect of clusterin on oxidative stress-induced cell death of human corneal endothelial cells. Mol Vis (2009) 0.94
Protective effect of uridine on cornea in a rabbit dry eye model. Invest Ophthalmol Vis Sci (2007) 0.94
Corneal wasp sting accompanied by optic neuropathy and retinopathy. Jpn J Ophthalmol (2011) 0.94
Clinical comparison of ciliary sulcus and pars plana locations for posterior chamber intraocular lens transscleral fixation. J Cataract Refract Surg (2011) 0.92
In situ intraocular suture techniques for pupilloplasty and suspension of a subluxated intraocular lens. Ophthalmic Surg Lasers Imaging (2010) 0.91
Cytokine secretion by human mesenchymal stem cells cocultured with damaged corneal epithelial cells. Cytokine (2009) 0.91
Cytotoxicity of voriconazole on cultured human corneal endothelial cells. Antimicrob Agents Chemother (2011) 0.90
The effect of pterygium surgery on contrast sensitivity and corneal topographic changes. Clin Ophthalmol (2010) 0.90
Preliminary effects of oral uridine on the ocular surface in dry eye patients. J Korean Med Sci (2009) 0.90
Short term effects of topical cyclosporine and viscoelastic on the ocular surfaces in patients with dry eye. Korean J Ophthalmol (2007) 0.90
The effect of amantadine on corneal endothelium in subjects with Parkinson's disease. Ophthalmology (2010) 0.90
Five-year results of corneal tattooing for cosmetic repair in disfigured eyes. Cornea (2011) 0.89
The effect of different suturing techniques on astigmatism after penetrating keratoplasty. J Korean Med Sci (2008) 0.89
Effects of multicurve RGP contact lens use on topographic changes in keratoconus. Korean J Ophthalmol (2010) 0.88
Investigating the relationship between serum interleukin-17 levels and systemic immune-mediated disease in patients with dry eye syndrome. Korean J Ophthalmol (2011) 0.88
Changes of ocular higher order aberration in on- and off-eye of rigid gas permeable contact lenses. Optom Vis Sci (2007) 0.87
Long-term visual outcomes of penetrating keratoplasty for Peters anomaly. Graefes Arch Clin Exp Ophthalmol (2012) 0.87
Optic neuritis in Asian children. J Pediatr Ophthalmol Strabismus (2002) 0.87
A case of corneal endothelial deterioration associated with retained Descemet's membrane after penetrating keratoplasty. Jpn J Ophthalmol (2009) 0.86
The anti-inflammatory effect of subconjunctival bevacizumab on chemically burned rat corneas. Curr Eye Res (2009) 0.85
Oral alcohol administration disturbs tear film and ocular surface. Ophthalmology (2012) 0.85
Primary sebaceous carcinoma of the corneaoscleral limbus with pagetoid recurrence. Korean J Ophthalmol (2009) 0.85
Clinical outcome of penetrating keratoplasty in patients 5 years or younger: peters anomaly versus sclerocornea. Cornea (2013) 0.85
Long-term outcome in ocular intractable surface disease with Seoul-type keratoprosthesis. Cornea (2007) 0.84
Chemical injury-induced corneal opacity and neovascularization reduced by rapamycin via TGF-β1/ERK pathways regulation. Invest Ophthalmol Vis Sci (2013) 0.84
Evaluation of corneal biomechanical properties following penetrating keratoplasty using the ocular response analyzer. Korean J Ophthalmol (2010) 0.84
Rapamycin reduces reactive oxygen species in cultured human corneal endothelial cells. Curr Eye Res (2011) 0.84
Infliximab for progressive peripheral ulcerative keratitis in a patient with juvenile rheumatoid arthritis. Jpn J Ophthalmol (2011) 0.84
Contrast sensitivity after LASIK, LASEK, and wavefront-guided LASEK with the VISX S4 laser. J Refract Surg (2007) 0.83
The epidemiology of cosmetic treatments for corneal opacities in a Korean population. Korean J Ophthalmol (2010) 0.83
Long-term outcomes of first-line treatment with doxycycline in patients with previously untreated ocular adnexal marginal zone B cell lymphoma. Ann Hematol (2014) 0.83
Effect of base curve radius of therapeutic lenses on epithelial healing after laser-assisted subepithelial keratectomy. Korean J Ophthalmol (2007) 0.83
VSX1 gene and keratoconus: genetic analysis in Korean patients. Cornea (2012) 0.83
Effect of age and early intervention with a systemic steroid, intravenous immunoglobulin or amniotic membrane transplantation on the ocular outcomes of patients with Stevens-Johnson syndrome. Korean J Ophthalmol (2013) 0.83
Juvenile xanthogranuloma presenting as infiltrative conjunctival mass in an adult. Cornea (2012) 0.83
Long-term outcome and prognostic factor analysis for keratolimbal allografts. Graefes Arch Clin Exp Ophthalmol (2011) 0.83
A case of epidemic keratoconjunctivitis complicated by Alcaligenes xylosoxidans infection. Korean J Ophthalmol (2005) 0.83
Protective effect of ascorbic Acid against corneal damage by ultraviolet B irradiation: a pilot study. Cornea (2008) 0.82
Argon laser photoablation of conjunctival pigmented nevus. Am J Ophthalmol (2006) 0.82
Histological differences in full-thickness vs. lamellar corneal pig-to-rabbit xenotransplantation. Vet Ophthalmol (2009) 0.82
Gal alpha(1-3)Gal expression of the cornea in vitro, in vivo and in xenotransplantation. Xenotransplantation (2007) 0.82
Comparison of clinical outcomes of same-size grafting between deep anterior lamellar keratoplasty and penetrating keratoplasty for keratoconus. Korean J Ophthalmol (2013) 0.82
Clinical performance and fitting characteristics with a multicurve lens for keratoconus. Eye Contact Lens (2004) 0.82
Cosmetic improvement of nevus of Ota by scleral allograft overlay. Can J Ophthalmol (2011) 0.82
Mesenchymal stem/stromal cells inhibit the NLRP3 inflammasome by decreasing mitochondrial reactive oxygen species. Stem Cells (2014) 0.82
Comparative cross-sectional analysis of the effects of topical antiglaucoma drugs on the ocular surface. Adv Ther (2013) 0.82